Maplelane Capital’s ASML ASML Stock Holding History

Maplelane Capital’s Portfolio ASML Stock Details ASML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$19.8M	Sell	15,000 -12,500	-45%	-$17.1M	0.71%	41
2025 Q4	$29.4M	Buy	+27,500	New	+$28.7M	1.04%	30
2025 Q3	–	Sell	-28,611	Closed	-$22.9M	–	94
2025 Q2	$22.9M	Sell	28,611 -53,389	-65%	-$38.3M	0.64%	46
2025 Q1	$54.3M	Buy	+82,000	New	+$59.7M	2.24%	13
2024 Q3	–	Sell	-92,500	Closed	-$95.5M	–	75
2024 Q2	$95.5M	Buy	92,500 +85,500	+1,221%	+$82.2M	3.27%	6
2024 Q1	$6.74M	Buy	+7,000	New	+$6.21M	0.22%	67
2021 Q3	–	Sell	-36,000	Closed	-$24.9M	–	95
2021 Q2	$24.9M	Buy	+36,000	New	+$23.7M	0.81%	37
2018 Q1	–	Sell	-1	Closed	–	–	135
2017 Q4	$0	Hold	1	–	–	﹤0.01%	117
2017 Q3	$0	Buy	+1	New	+$153	﹤0.01%	137
2015 Q2	–	Sell	-1	Closed	–	–	126
2015 Q1	$0	Buy	+1	New	+$105	﹤0.01%	147
2014 Q3	–	Sell	-1	Closed	-$94	–	138
2014 Q2	$0	Buy	+1	New	+$86	﹤0.01%	115

Other funds holding ASML

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Maplelane Capital's ASML Position: Q1 2026 in Review

Maplelane Capital reduced its ASML (ASML) stake by 45% in Q1 2026, selling an estimated $17.1M and leaving 15,000 shares worth $19.8M. The position accounts for 0.71% of the portfolio, ranked #41.

Maplelane Capital first reported a position in ASML in Q2 2014 and has held it in 11 quarters since. The position peaked at $95.5M in Q2 2024. 2,188 funds tracked by Wall St. Rank hold ASML as of Q1 2026.

Maplelane Capital held 15,000 shares of ASML worth $19.8M as of Q1 2026.
Maplelane Capital sold 12,500 ASML shares in Q1 2026, an estimated $17.1M.
ASML made up 0.71% of Maplelane Capital's portfolio in Q1 2026, its #41 holding.
Maplelane Capital first reported a position in ASML in Q2 2014 and has held it in 11 quarters since.
Maplelane Capital's ASML position peaked at $95.5M in Q2 2024.
2,188 funds tracked by Wall St. Rank held ASML as of Q1 2026.

Based on Maplelane Capital's 13F filing for Q1 2026, filed 14 May 2026.